Follow-up of renal cell carcinoma in a nonmetastatic stage

被引:0
|
作者
Szabados, B. [1 ]
Foller, S. [2 ]
Schulz, G. B. [3 ]
Staehler, M. [3 ]
Grimm, M. -O. [2 ]
Stief, C. G. [3 ]
Casuscelli, J. [3 ]
机构
[1] Queen Mary Univ London, Barts Canc Inst, London, England
[2] Univ Klinikum Jena, Urol Klin, Jena, Germany
[3] Klinikum Univ Munchen, Urol Klin & Poliklin, Campus Grosshadern,Marchioninistr 15, D-81377 Munich, Germany
来源
ONKOLOGE | 2019年 / 25卷 / 04期
关键词
Kidney neoplasms; Postoperative care; Complications; Relapse; Guidelines; NEPHRON-SPARING SURGERY; RADICAL NEPHRECTOMY; BRAIN METASTASIS; LATE RECURRENCE; SURVEILLANCE; GUIDELINES; VALIDATION; RISK; ASSOCIATION; PATTERNS;
D O I
10.1007/s00761-019-0563-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Postoperative follow-up care after curative surgery or ablative treatment is the standard of care in patients with nonmetastatic renal cell carcinoma. The goal is to identify and treat postoperative complications and local recurrences early on. Follow-up investigations and their relevance are widely acknowledged and validated and patients undergoing follow-up seem to benefit from alonger survival in nonmetastatic renal cell carcinoma. Hence there is no consensus on a standardized follow-up strategy. The most disputed question is around the frequency of the investigations and the duration of the follow-up. Without an evidence-based follow-up protocol, urologists should carry out an individualized, potentially lifelong follow-up regimen, which also includes the patients' needs and perspectives.
引用
收藏
页码:379 / 390
页数:12
相关论文
共 50 条
  • [31] Natural history of renal cell carcinoma: a case with 18 years follow-up
    Fumitake Kai
    Tatsuya Takayama
    Toshiki Ito
    Shinsuke Hadano
    Seiichiro Ozono
    Clinical and Experimental Nephrology, 2011, 15 : 312 - 315
  • [32] Natural history of renal cell carcinoma: a case with 18 years follow-up
    Kai, Fumitake
    Takayama, Tatsuya
    Ito, Toshiki
    Hadano, Shinsuke
    Ozono, Seiichiro
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2011, 15 (02) : 312 - 315
  • [33] Renal cell carcinoma: A clinicopathological follow-up study after radical nephrectomy
    Zubac, Dragomir P.
    Bostad, Leif
    Gestblom, Charlotta
    Kihl, Bjorn
    Seidal, Tomas
    Wentzel-Larsen, Tore
    Bakke, August M.
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2007, 41 (03): : 191 - 197
  • [34] Renal cell carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
    Escudier, B.
    Kataja, V.
    ANNALS OF ONCOLOGY, 2009, 20 : 81 - 82
  • [35] Re: Guideline of Guidelines: Follow-up after Nephrectomy for Renal Cell Carcinoma
    Laguna, M. Pilar
    JOURNAL OF UROLOGY, 2016, 196 (02): : 349 - 350
  • [36] Whole-body MRI in follow-up of patients with renal cell carcinoma
    Platzek, Ivan
    Zastrow, Stefan
    Deppe, Pierre-Emanuel
    Grimm, Marc-Oliver
    Wirth, Manfred
    Laniado, Michael
    Stroszczynski, Christian
    ACTA RADIOLOGICA, 2010, 51 (05) : 581 - 589
  • [37] Follow-up After Treatment for Renal Cell Carcinoma: The Evidence Beyond the Guidelines
    Capogrosso, Paolo
    Capitanio, Umberto
    La Croce, Giovanni
    Nini, Alessandro
    Salonia, Andrea
    Montorsi, Francesco
    Bertini, Roberto
    EUROPEAN UROLOGY FOCUS, 2016, 1 (03): : 272 - 281
  • [38] Recurrence of surgically resected chromophobe renal cell carcinoma: Recommendations for follow-up
    Saiz, Leyre Vanaclocha
    Neves, Joana B.
    Marchetti, Marta
    Barod, Ravi
    Patki, Prasad
    Mumtaz, Faiz
    Dabestani, Saeed
    Tran, Maxine Gia Binh
    Bex, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [39] Nachsorge beim Nierenzellkarzinom im nicht fernmetastasierten StadiumFollow-up of renal cell carcinoma in a nonmetastatic stage
    B. Szabados
    S. Foller
    G. B. Schulz
    M. Staehler
    M.-O. Grimm
    C. G. Stief
    J. Casuscelli
    Der Onkologe, 2019, 25 (4): : 379 - 390
  • [40] THE BLIND SPOTS IN FOLLOW-UP AFTER NEPHRECTOMY FOR LOCALISED RENAL CELL CARCINOMA
    van Oostenbrugge, Tim
    Kroeze, Stephanie
    Bosch, Ruud
    van Melick, Harm
    JOURNAL OF UROLOGY, 2013, 189 (04): : E752 - E753